Seeking Alpha

wretchedturkey

wretchedturkey
Send Message
View as an RSS Feed
View wretchedturkey's Comments BY TICKER:
Latest  |  Highest rated
  • Google Dumps Moto: Microsoft's Strategy Questioned, Immersion Benefits [View article]
    Paolo, I don't think most people would agree that Google's purchase of Motorola was a failure - considering that they kept a vast majority of the assets that have actual value to Google. Google was never in the phone manufacturing game so picking Motorola a part for their needs sounds like a solid move to me, IMO.
    Feb 2 05:49 PM | Likes Like |Link to Comment
  • Vringo: How To Lose At Winning [View article]
    Does the market actually believe that VRNG is worse off now with a 6.5% judgment in hand than prior to it???
    Jan 30 01:44 PM | 1 Like Like |Link to Comment
  • Vringo: How To Lose At Winning [View article]
    How is VRNG almost below its PPS prior to the news blast?? In a word... WOW!
    Jan 30 01:42 PM | 1 Like Like |Link to Comment
  • Vringo: How To Lose At Winning [View article]
    I also agree.
    Jan 30 01:33 PM | 2 Likes Like |Link to Comment
  • Vringo: How To Lose At Winning [View article]
    Why are so many commentators missing the bigger picture here? That the typical retail investor sold out yesterday!!!

    After all the backslapping and hoohawing and chestpumping over the past few years, they sell out asap? Clearly it proves that they were desperate to get out ASAP and move on. Clearly these are NOT true believers in the stock and are merely lottery-ticket toking retail speculators. And THIS is what the shorts know of and know how to attack well.

    Anyone truly & honestly long on VRNG should not have sold out but rather hold on due to the belief that the stock didn't hit higher points due to the appeals and the fact that the stock needs a new round of marketing and pumping - at that point and only then should true longs leave the stock - once the next round of lottery-ticket toting retail speculators jump in...

    For people to sell out now when there are many other irons in the fire is downright silly. VRNG has now proved that it deserves a multiplier since it proved it can generate ongoing revenues from its patent portfolio. This takes some time and regular "wins" to do so. Sellers of yesterday and today truly had no business being in the stock to begin with.
    Jan 30 11:31 AM | 6 Likes Like |Link to Comment
  • GigaMedia Ltd.: A $1 Stock With $1.47/Share Cash And Significant Growth Prospects [View article]
    stok, while I agree that GIGM is excitedly undervalued. I'm a little bit more apprehensive as to its chances of breaking out. There are many undervalued opportunities in the market, the real question is to identify those that will move in a time frame that one is comfortable waiting for.

    I'm lightly long on GIGM but I'm not yet convinced that 2014 is the year for GIGM.
    Jan 28 09:03 PM | Likes Like |Link to Comment
  • Chelsea Therapeutics And Venaxis Incorporated - Top Pics For Big Gains In Q1 [View article]
    PS - Never said your analysis is wrong. As I used to be long too, I actually agree with the bullish aspects of your analysis. I just want to understand why you don't believe in the risks.
    Jan 11 07:25 PM | Likes Like |Link to Comment
  • Chelsea Therapeutics And Venaxis Incorporated - Top Pics For Big Gains In Q1 [View article]
    Actually, I was never short, only long (and obviously burned). At this point, I am only interested in the story and not interested in CHTP as an investment thesis in either direction. Unlike you, I am actually open-minded to contrary investment ideas and feel this could go either way and therefore prefer to simply watch.

    My only interested in poking the lion is for you to offer your followers an explanation as to what went wrong. Your articles continually marginalized the risks here without any real explanation as to why that was. I have pushed you for this without a proper answer.
    This, you owe to your followers.
    Jan 11 07:22 PM | Likes Like |Link to Comment
  • Chelsea Therapeutics And Venaxis Incorporated - Top Pics For Big Gains In Q1 [View article]
    Bob, I'm sure you saw THIS coming.

    I hope you are working on an explanation WHY this happened and explain why it diverged from your analysis.

    Don't get me wrong, I am not suggesting a mea culpa from you - everyone is entitled to their opinions, however as you were so adamantly bullish on CHTP, I do expect an explanation as to where or why your analysis was off.
    Thank you.
    Jan 10 10:02 AM | Likes Like |Link to Comment
  • NQ Mobile - Special Attestation Report [View article]
    @Simon, do you have any confirmation bias in your comments?

    You bring 4 instances one way. Are there any instances the other way?

    I am not trying to be facetious or anything; I am simply unfamiliar with MW and unfamiliar with their 'track record'.

    So, how many have they gotten right, and how many wrong?
    Jan 3 12:26 PM | Likes Like |Link to Comment
  • Mart Resources Is Not Currently A Sub-Saharan Oasis In The African Energy Patch [View article]
    Makes sense to me sc21.

    But I'm sure the market (that dictated the pps drop) sees the loss of production as an unexpected loss in revenues and therefore Mart got hit accordingly. If you are correct however, then it means that when Mart next reports revenues/net income, it will positively surprise the market and the pps should spike back to the original levels prior to the news.

    sc21, do you agree?
    Jan 3 12:23 PM | Likes Like |Link to Comment
  • Why Doesn't The Dividend Growth ETF Grow Its Dividends? [View article]
    I agree with Roger. I get the sense that many on the SA forum are not like the casual person and are probably a little bit more attuned to their investing activities and get a greater satisfaction out of following and working on their portfolios.

    Specifically for myself, I see it more as a hobby or leisure activity than working or some other menial task.
    Jan 3 12:19 PM | 3 Likes Like |Link to Comment
  • NQ Mobile - Special Attestation Report [View article]
    halfraw, there is nothing emotional about calling for a Special Attestation Report. As Skytides discloses, he has no 'skin' in the game. He is merely offering a suggestion for what NQ should do to get the proverbial monkey off their back.

    Suggesting that the article is not objective but rather emotional, suggests your own state of mind and 'which side of the fence' you sit on.
    Jan 3 12:14 PM | 2 Likes Like |Link to Comment
  • NQ Mobile - Special Attestation Report [View article]
    Skytides, thank you for the article that helps the typical investor understand better our role (I'm a CPA, CA from Canada myself).
    I don't care much for NQ itself but thank you for clarifying to others what should be done by NQ considering the circumstances.

    I have suggested similar ideas when discussing NQ with collegues and peers.

    For NQ to rid itself completely of the MW issue, they definitely require going above and beyond normal protocol of an audit of historical financial statements. Personally, I have this gut feeling that MW is actually right, but who really knows... I'm enjoying the show and looking forward to the next installment in this drama!
    Jan 3 12:11 PM | 1 Like Like |Link to Comment
  • Chelsea Therapeutics And Venaxis Incorporated - Top Pics For Big Gains In Q1 [View article]
    Except that CHTP has already said several times it will NOT carry out a new study (because it lacks the funding or enough patients), rather it wants to use 306b as the basis for a study and simply add on to it.

    The FDA has flip-flopped on this as originally they did not like that idea but after much pandering by CHTP's directors, FDA agreed to allow CHTP to use it as a basis for a new study (probably because of Northera's orphan drug status).

    As of today, there is no more likelihood than not of an FDA approval it is an absolute coin flip and people who follow CHTP must be cognizant of this. If it gets approved, the stock instantly pops handsomely over its current pps (my guess is it will pop to about $9.00-$12.00), if rejected, it falls to the $1.00-$1.50 range (this is my guess).

    So, speculators, do you like the risk reward profile? It fell 10%+ today, so we're looking at currently 3.60 popping to $9-$12 or falling to $1-$1.5.
    Please "like" this comment if you agree with my assessment of the current status of Northera.
    Jan 3 12:04 PM | 1 Like Like |Link to Comment
COMMENTS STATS
502 Comments
673 Likes